Key result
Catheter ablation of Purkinje triggers and substrates linked to ~91% freedom from recurrent VF.
Why the study?
The study was conducted to evaluate mapping and ablation of ventricular fibrillation substrates or triggers in early repolarization syndromes or J-wave syndrome.
Does mapping and ablation reduce VF recurrences in patients with early repolarization syndrome and recurrent VF?
Observational (n=52)
Open-label
Yes
Does mapping and ablation reduce VF recurrences in patients with early repolarization syndrome and recurrent VF?
Ablation of VF substrates or triggers is highly effective in preventing VF recurrences in patients with early repolarization syndrome and frequent VF episodes.
Answers are grounded in this paper and cite their sources.
May support ablation for recurrent VF in early repolarization syndrome; leaves open need for randomized confirmation.
Background: We conducted a multicenter study to evaluate mapping and ablation of ventricular fibrillation (VF) substrates or VF triggers in early repolarization syndromes (ERS) or J-wave syndrome (JWS). Methods: We studied 52 patients with ERS (4 women; median age, 35 years) with recurrent VF episodes. Body surface electrocardiographic imaging and endocardial and epicardial electroanatomical mapping of both ventricles were performed during sinus rhythm and VF for localization of triggers, substrates, and drivers. Ablations were performed on VF substrates, defined as areas that had late depolarization abnormalities characterized by low-voltage fractionated late potentials, and VF triggers. Results: Fifty-one of the 52 patients had detailed mapping that revealed 2 phenotypes: group 1 had late depolarization abnormalities predominantly at the right ventricular (RV) epicardium (n=40), and group 2 had no depolarization abnormalities (n=11). Group 1 can be subcategorized into 2 groups: Group 1A included 33 patients with ERS with Brugada electrocardiographic pattern, and group 1B included 7 patients with ERS without Brugada electrocardiographic pattern. Late depolarization areas colocalize with VF driver areas. The anterior RV outflow tract/RV epicardium and the RV inferior epicardium are the major substrate sites for group 1. The Purkinje network is the leading underlying VF trigger in group 2 that had no substrates. Ablations were performed in 43 patients: 31 and 5 group 1 patients had only VF substrate ablation and VF substrates plus VF trigger, respectively (mean, 1.4±0.6 sessions); 6 group 2 patients and 1 patient without group classification had only Purkinje VF trigger ablation (mean, 1.2±0.4 sessions). Ablations were successful in reducing VF recurrences ( P <0.0001). After follow-up of 31±26 months, 39 (91%) had no VF recurrences. Conclusions: There are 2 phenotypes of ERS/J-wave syndrome: one with late depolarization abnormality as the underlying mechanism of high-amplitude J-wave elevation that predominantly resides in the RV outflow tract and RV inferolateral epicardium, serving as an excellent target for ablation, and the other with pure ERS devoid of VF substrates but with VF triggers that are associated with Purkinje sites. Ablation is effective in treating symptomatic patients with ERS/J-wave syndrome with frequent VF episodes.
No takes yet. Share an insight, caveat, or question.
Nademanee et al. (2019) conducted an observational in Early repolarization syndrome (ERS) / J-wave syndrome (JWS) with recurrent ventricular fibrillation (n=52). Catheter ablation of VF substrates and/or VF triggers vs. Pre-ablation baseline / non-ablated patients was evaluated on Freedom from ventricular fibrillation recurrence (p=<0.0001). Catheter ablation of VF substrates and Purkinje triggers reduced VF recurrences, with 91% of patients remaining free of VF over 31±26 months of follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: